Organization
Palvella Therapeutics
2 clinical trials
Clinical trial
A Multicenter, Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Multicenter Open-Label Treatment Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia CongenitaStatus: Recruiting, Estimated PCD: 2023-10-01